Actigraphy Study Endpoints to Reduce Sample Size and Facilitate Drug Development for Pediatric Pulmonary Arterial Hypertension

Sun, H., Stockbridge, N., Ivy, D. D., Clark, J., Bates, A., Handler, S. S., Krishnan, U. S., Mullen, M. P., Yung, D., Hopper, R. K., Varghese, N. P., Avitabile, C. M., Fineman, J., Austin, E. D., & Freire, G. (2025). Actigraphy Study Endpoints to Reduce Sample Size and Facilitate Drug Development for Pediatric Pulmonary Arterial Hypertension. The Journal of Pediatrics, 277, 114383. https://doi.org/10.1016/j.jpeds.2024.114383
Authors:
Haihao Sun
Norman Stockbridge
D Dunbar Ivy
Jennifer Clark
Angela Bates
Stephanie S Handler
Usha S Krishnan
Mary P Mullen
Delphine Yung
Rachel K Hopper
Nidhy P Varghese
Catherine M Avitabile
Jeff Fineman
Eric D Austin
Grace Freire
Affiliated Authors:
Usha S Krishnan
Author Keywords:
6mwd
clinical trials
drug development
heart rate variability
pediatric pah
study endpoints
Publication Type:
Article
Unique ID:
10.1016/j.jpeds.2024.114383
PMID:
Publication Date:
Data Source:
PubMed

Record Created: